GOLD FINGERS

K971183 · Alliance Rubber Products Sdn. Bhd. · LYY · Aug 8, 1997 · General Hospital

Device Facts

Record IDK971183
Device NameGOLD FINGERS
ApplicantAlliance Rubber Products Sdn. Bhd.
Product CodeLYY · General Hospital
Decision DateAug 8, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 880.6250
Device ClassClass 1

Intended Use

A medical gloves is worn on the hand of health care and similar personnel to prevent contamination between health care personnel and the patient.

Device Story

Latex patient examination gloves; powder-free; intended for use by healthcare personnel to provide a barrier against contamination between the wearer and the patient. Device is worn on the hands in clinical or similar settings.

Clinical Evidence

Bench testing only.

Technological Characteristics

Latex material; powder-free; includes water extractable protein labeling claim.

Indications for Use

Indicated for use by healthcare and similar personnel to prevent cross-contamination between the wearer and the patient.

Regulatory Classification

Identification

A non-powdered patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. A non-powdered patient examination glove does not incorporate powder for purposes other than manufacturing. The final finished glove includes only residual powder from manufacturing.

Related Devices

Submission Summary (Full Text)

{0} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Chua Hooi Koon Alliance Rubbert Products Sdn. Bhd. 878 Jalan Bandar Baru, Sungei Kecil 14300 Nibong Tebal Pulau Pinang, MALAYSIA AUG - 8 1997 Re: K971183 Trade Name: Gold Finger Latex Patient Examination Gloves, Powder-Free with water extractable protein labeling claim Regulatory Class: I Product Code: LYY Dated: July 14, 1997 Received: July 16, 1997 Dear Mr. Koon: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical {1} Page 2 - Mr. Koon Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the *Federal Register*. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for *in vitro* diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2} Alliance Rubber Products Sdn.Bhd. 878, Jalan Bar dar Baru, Sungei Kecil, 14300 Nibong Tebal, Pulau Pinang, Malaysia. Tel: (04)-5932235, 5937616 Fax: (04)-5932262, 3322034 Company No.: 52446-U Your Ref : Our Ref :CHK/130397/5 Date: 13-03-97 # ATTACHMENT 2: ## INDICATION FOR USE Applicant: ALLIANCE RUBBER PRODUCTS SDN. BHD. 510(k) Number (if known): K971183 Device Name: LATEX EXAMINATION GLOVES, POWDER FREE with water extractable protein labeling claim Trade Name: (1) GOLD FINGERS (2) FOODHANDLER (3) Other clients private labelling Indication For Use: A medical gloves is worn on the hand of health care and similar personnel to prevent contamination between health care personnel and the patient. Concurrence of CDRH Office of Device Evaluation (ODE) ![img-0.jpeg](img-0.jpeg) Prescription Use ☐ Per 21 CFR 801.109 OR Over-The-Counter ☑
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%